ES2531085T3 - Fracciones de permeado de suero de leche y su uso para la prevención y la terapia de diabetes de tipo 2 y de síndrome metabólico - Google Patents
Fracciones de permeado de suero de leche y su uso para la prevención y la terapia de diabetes de tipo 2 y de síndrome metabólico Download PDFInfo
- Publication number
- ES2531085T3 ES2531085T3 ES07788206T ES07788206T ES2531085T3 ES 2531085 T3 ES2531085 T3 ES 2531085T3 ES 07788206 T ES07788206 T ES 07788206T ES 07788206 T ES07788206 T ES 07788206T ES 2531085 T3 ES2531085 T3 ES 2531085T3
- Authority
- ES
- Spain
- Prior art keywords
- diabetes
- fractions
- therapy
- prevention
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
- A23J1/205—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey from whey, e.g. lactalbumine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Peptides Or Proteins (AREA)
Abstract
Fracción aislada de permeado de suero de leche dulce que comprende uno o varios polipéptidos con una masa de 100 a 3500 Dalton, preferiblemente de 200 a 3000 Dalton.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006036285A DE102006036285A1 (de) | 2006-08-03 | 2006-08-03 | Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms |
PCT/EP2007/058073 WO2008015275A1 (de) | 2006-08-03 | 2007-08-03 | Fraktionen aus molkepermeat und deren verwendung zur prävention und therapie des typ-2 diabetes und des metabolischen syndroms |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2531085T3 true ES2531085T3 (es) | 2015-03-10 |
Family
ID=38670475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES07788206T Active ES2531085T3 (es) | 2006-08-03 | 2007-08-03 | Fracciones de permeado de suero de leche y su uso para la prevención y la terapia de diabetes de tipo 2 y de síndrome metabólico |
Country Status (5)
Country | Link |
---|---|
US (1) | US9877995B2 (es) |
EP (1) | EP2048969B1 (es) |
DE (1) | DE102006036285A1 (es) |
ES (1) | ES2531085T3 (es) |
WO (1) | WO2008015275A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2008341009B2 (en) * | 2007-12-21 | 2011-05-19 | Dairy Innovation Australia Pty Ltd | Processing of dairy ingredients by ultra-sonication |
WO2012131008A2 (en) | 2011-03-29 | 2012-10-04 | Chr. Hansen A/S | Inactivation of bacteriophages in a liquid |
US11524977B2 (en) * | 2017-11-13 | 2022-12-13 | Jiangsu University | Ultrasound-assisted simulated digestion method of milk protein active peptide and application thereof in health foods |
CN108786766A (zh) * | 2018-05-04 | 2018-11-13 | 浙江工业大学 | 一种基于衣康酸键合硅胶的亲水色谱固定相及其制备方法 |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2903579A1 (de) | 1978-02-03 | 1979-08-09 | Sigma Tau Ind Farmaceuti | Verwendung von acetylcarnitin und anderen acylderivaten des carnitins zur behandlung der hyperlipoproteinaemie und hyperlimpidaemie sowie arzneimittel |
DE2903558C2 (de) | 1978-02-03 | 1994-09-01 | Sigma Tau Ind Farmaceuti | Verwendung von L-Carnitin |
JPS6263553A (ja) | 1985-09-17 | 1987-03-20 | Snow Brand Milk Prod Co Ltd | L−カルニチンの調製方法 |
JPS6387944A (ja) | 1986-10-02 | 1988-04-19 | Chugai Pharmaceut Co Ltd | 乳清ミネラルおよびその利用 |
US5213826A (en) | 1987-11-05 | 1993-05-25 | Land O'lakes, Inc. | Whey permeate-derived sweetener |
WO1993012807A1 (en) * | 1991-12-26 | 1993-07-08 | Snow Brand Milk Products Co., Ltd. | Bone reinforcing factor, and food and drink containing said factor |
IT1263004B (it) | 1992-10-08 | 1996-07-23 | Sigma Tau Ind Farmaceuti | Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti. |
GB9312369D0 (en) * | 1993-06-16 | 1993-07-28 | Sandoz Nutrition Ltd | Organic compounds |
US6096870A (en) * | 1994-01-05 | 2000-08-01 | Sepragen Corporation | Sequential separation of whey |
US5639501A (en) | 1995-01-31 | 1997-06-17 | Vembu; Rajan | Separation of minerals from whey permeate |
US7094949B2 (en) * | 1995-05-16 | 2006-08-22 | A2 Corporation Limited | Breeding and milking cows for milk free of β-casein A1 |
DE29623285U1 (de) | 1996-10-25 | 1998-01-22 | Privates Institut Bioserv GmbH, 18059 Rostock | Geschmacksneutrale Mikrokapseln und diese enthaltende Lebens- oder Futtermittel |
AUPP051497A0 (en) * | 1997-11-24 | 1997-12-18 | University Of Melbourne, The | Antimicrobial peptides |
FI104783B (fi) | 1998-02-12 | 2000-04-14 | Valio Oy | Herasuolajauhe, menetelmä sen valmistamiseksi ja sen käyttö |
EP1087668B1 (en) * | 1998-06-17 | 2004-09-15 | New Zealand Dairy Board | Bioactive whey protein hydrolysate |
DE19854749A1 (de) | 1998-11-27 | 2000-05-31 | Privates Inst Bioserv Gmbh | Verwendung von Kapseln, die eine oder mehrere antigene Substanzen enthalten, zur Prävention und/oder Behandlung von Autoimmunerkrankungen |
CN1339964A (zh) | 1999-02-19 | 2002-03-13 | 生化研究股份公司 | 用以生产微胶囊的生物可降解复合材料 |
GB9927603D0 (en) | 1999-11-22 | 2000-01-19 | Nestle Sa | Use of a milk protein hydrolysate in the treatment of diabetes |
JP4701472B2 (ja) | 2000-04-21 | 2011-06-15 | 雪印乳業株式会社 | 乳カルシウム組成物の製造方法 |
JP2002037738A (ja) | 2000-07-25 | 2002-02-06 | Kotobuki Chemical:Kk | 脂肪前駆細胞から脂肪細胞への分化抑制剤とこの脂肪細胞への分化抑制剤に用いる活性化乳清及びその活性化乳清の製造方法。 |
US6592863B2 (en) * | 2000-08-22 | 2003-07-15 | Nestec S.A. | Nutritional composition |
US6465432B1 (en) * | 2000-08-28 | 2002-10-15 | Kraft Food Holdings, Inc. | Isolated antioxidant peptides form casein and methods for preparing, isolating, and identifying antioxidant peptides |
NZ507335A (en) * | 2000-10-05 | 2004-10-29 | New Zealand Dairy Board | Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP |
CA2426508A1 (en) * | 2000-10-23 | 2002-05-16 | Bristol-Myers Squibb Company | Modulators of bruton's tyrosine kinase and bruton's tyrosine kinase intermediates and methods for their identification and use in the treatment and prevention of osteoporosis and related disease states |
AU2002234561B2 (en) * | 2000-12-07 | 2007-01-18 | Dsm Ip Assets B.V. | Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
WO2003007730A1 (en) * | 2001-07-18 | 2003-01-30 | Dsm Ip Assets B.V. | Process for the hydrolysis of milk proteins |
DE10135493A1 (de) | 2001-07-20 | 2003-01-30 | Jobst Krauskopf | Pharmazeutische Zusammensetzung zur Behandlung von Hypercholesterinämie |
DE10135494A1 (de) | 2001-07-20 | 2003-11-06 | Jobst Krauskopf | Verwendung eines Lactatsalzes zur Behandlung und Prophylaxe der Athereosklerose |
US20030118662A1 (en) | 2001-12-05 | 2003-06-26 | Glanbia Foods, Inc. | Therapeutic uses of milk mineral fortified food products |
US20030166866A1 (en) * | 2002-01-28 | 2003-09-04 | Land O' Lakes, Inc. | Method of processing a proteinaceous material to recover K-casein macropeptide and polymers of a-lactalbumin and B-lactoglobulin |
GB0213612D0 (en) | 2002-06-13 | 2002-07-24 | Novartis Nutrition Ag | Organic compounds |
FR2841473B1 (fr) * | 2002-06-27 | 2004-09-17 | Ingredia | Utilisation d'au moins un peptide de la caseine s2 a activite inhbitrice de l'enzyme de conversion de l'engiotensine i pour la preparation de medicaments, d'aliments et de complements alimentaires |
DE10233229A1 (de) | 2002-07-22 | 2004-02-12 | S.K. Enterprise Gmbh | Pharmazeutische Zusammensetzung zur Senkung des Triglyceridspiegels |
US20040162414A1 (en) * | 2002-11-22 | 2004-08-19 | Santora Ling C. | Method for reducing or preventing modification of a polypeptide in solution |
JP2006510367A (ja) | 2002-12-20 | 2006-03-30 | ユニリーバー・ナームローゼ・ベンノートシヤープ | 血糖調節組成物 |
CA2531058A1 (en) | 2003-06-30 | 2005-01-06 | Nestec S.A. | Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus |
DE10331202A1 (de) * | 2003-07-10 | 2005-03-31 | S.K. Enterprise Gmbh | Verwendung von Molkenpermeat zur Behandlung des Metabolischen Syndroms |
WO2005058344A1 (en) * | 2003-12-19 | 2005-06-30 | The University Of Melbourne | Antimicrobial composition |
US7799363B2 (en) * | 2004-10-07 | 2010-09-21 | Next Proteins, Inc. | Protein beverage and protein beverage concentrate and methods of making the same |
JP2008519988A (ja) * | 2004-11-12 | 2008-06-12 | ファイザー・インク | アミロイド−ベータペプチドを測定する方法 |
ES2319475B1 (es) * | 2005-06-08 | 2010-02-16 | Consejo Superior Investig. Cientificas | Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion. |
EP1907412B1 (en) * | 2005-06-30 | 2012-04-11 | Campina Nederland Holding B.V. | Peptides inhibiting angiotensin-converting enzyme |
RU2304167C2 (ru) | 2005-09-15 | 2007-08-10 | Общество с ограниченной ответственностью "МЕДБИОФАРМ-БИОТЕХ" | Способ получения гликопептидов и гликопептидный продукт, полученный этим способом, для использования в медицине |
US20070092632A1 (en) * | 2005-10-21 | 2007-04-26 | Stan Kubow | Ultra high pressure modified proteins and uses thereof |
US20070116802A1 (en) * | 2005-11-23 | 2007-05-24 | Carl Germano | High quality caloric composition |
AU2007343749B2 (en) * | 2006-12-20 | 2013-01-10 | Dupont Nutrition Biosciences Aps | Milk protein hydrolyzates with reduced immunogenic potential |
-
2006
- 2006-08-03 DE DE102006036285A patent/DE102006036285A1/de not_active Withdrawn
-
2007
- 2007-08-03 WO PCT/EP2007/058073 patent/WO2008015275A1/de active Application Filing
- 2007-08-03 US US12/376,146 patent/US9877995B2/en active Active
- 2007-08-03 ES ES07788206T patent/ES2531085T3/es active Active
- 2007-08-03 EP EP07788206.6A patent/EP2048969B1/de active Active
Also Published As
Publication number | Publication date |
---|---|
US20090274768A1 (en) | 2009-11-05 |
EP2048969B1 (de) | 2014-12-10 |
WO2008015275A1 (de) | 2008-02-07 |
US9877995B2 (en) | 2018-01-30 |
DE102006036285A1 (de) | 2008-02-07 |
EP2048969A1 (de) | 2009-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0907663A2 (pt) | ''composição que compreende hfo- 123 yf, composição que compreende hcfc-243db, composição que compreende hcfo- 1233xf, composição que comproeende hcfc- 244bb, uso das composições e método de uso das composições. | |
BRPI0814593A2 (pt) | Composto, composição farmacêutica que o contém e uso do composto. | |
CL2012003026A1 (es) | Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad. | |
BRPI0716495A2 (pt) | (r,r)-fenoterol e análogos de (r,r)- ou (r,s)-fenoterol, uso dos mesmos na preparação de composição farmacêutica e composição farmacêutica compreendendo o referidos compostos. | |
IL197831A (en) | Human antibodies that bind 4cxcr, preparations containing them and their uses | |
EA200802184A1 (ru) | Фармацевтические композиции с ингибиторами dpp iv | |
CL2007003523A1 (es) | Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad de pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso en el tratamiento profilactico o terapeutico del cancer | |
BRPI0918139A2 (pt) | composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos e uso | |
IL194550A (en) | Isolated antibodies or their fragments that bind to human protein tyrosine phosphate in a cell, their pharmaceutical preparations and their use | |
CL2008000008A1 (es) | Uso de un antigeno de circovirus porcino de tipo 2 (pcv2) para la profilaxis y tratamiento del complejo respiratorio porcino (prdc) y/o cualquier signo clinico asociado con prdc en un animal. | |
BRPI0719250A2 (pt) | Métodos e composições com opalescência reduzida. | |
BRPI0911203A2 (pt) | peptídeo ou derivado de peptídeo, composição farmacêutica, uso de um peptídeo ou derivado de peptídeo, métodos para tratar um paciente tendo uma deficiencia e para preparar o peptídeo ou derivado de peptídeo. | |
SV2008002906A (es) | Metodos y composiciones para modular la hemostasiaref. cho.0267b-sv | |
BRPI0922233A2 (pt) | compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas. | |
CL2008003546A1 (es) | Compuestos derivados de piridina; procedimiento de preparacion; composicion farmaceutica de dichos compuestos; y uso en el tratamiento y/o profilaxis de la diabetes mellitus tipo i y/o tipo ii. | |
EA201200484A1 (ru) | Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином | |
BRPI0814931A2 (pt) | Composto com atividade contra hcv, sua composição e seu uso | |
CL2008000304A1 (es) | Compuestos derivados de 1-oxa-3-azaespiro[4.5]decan-2-ona; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de un trastorno de la alimentacion, obesidad, depresion. | |
ES2531085T3 (es) | Fracciones de permeado de suero de leche y su uso para la prevención y la terapia de diabetes de tipo 2 y de síndrome metabólico | |
BR112012018970A2 (pt) | método para selagem aprimorada com fibrina | |
DK2160202T3 (da) | Sammensætninger som emmiterer positroner og indeholder uorganiske partikler, og anvendelse deraf i medicin, især ved diagnostiske processer | |
CL2008003602A1 (es) | Compuestos derivados de triazolotriazinas y triazolopirazinas sustituidas; composicion farmaceutica; y su uso en el tratamiento y/o profilaxis de trastornos hematologicos. | |
DK2012816T3 (da) | Anvendelse af Thymosin 1, alene eller i kombination med PTX3 eller Ganciclovir, til behandling af Cytomegalovirus infektion. | |
ATE541855T1 (de) | Weitere kristalline formen von rostafuroxin | |
RS53671B1 (en) | FVIII-Derived Peptides and Their Use in Tolerated Hemophiliacs |